瓦里安医疗大中华区总裁钱圣来：八赴进博之约，瓦里安以“中国智造”重塑癌症治疗新范式

Core Insights - Varian Medical showcased multiple cutting-edge cancer treatment technologies at the 8th China International Import Expo, including intelligent adaptive radiotherapy and AI-driven solutions, with three products making their global and Chinese debuts [1][2] - The company has evolved from being an exhibitor to an ecosystem builder in the Chinese market, reflecting the high-level opening and quality development of China's medical industry [1][2] Product Launch and Market Impact - Varian's Ethos AI-integrated adaptive radiotherapy platform received approval from China's National Medical Products Administration (NMPA) in April 2023, marking a significant step in the "exhibit to product" transition [2] - Ethos is currently used for clinical treatment of 72 cancer types globally, with 62 types in China, facilitating a shift from static planning to dynamic optimization in radiotherapy [2] - The collaboration with Siemens Healthineers introduced the Ethos+Free.Max cervical cancer treatment solution, integrating MRI precision imaging with adaptive radiotherapy for improved treatment outcomes [2] Strategic Transformation - Varian presented three major new products at the expo, emphasizing its transition from a device supplier to a solution platform, aiming to personalize radiotherapy and enhance automation [3][4] - The SmART solution is designed specifically for Chinese clinical settings, addressing the shortage of medical professionals and simplifying the adaptive radiotherapy process [3] Technological Advancements - The "intraoperative dual-rotation intensity-modulated" solution reduces treatment cycles from 6-7 weeks to 1 week, optimizing planning time by approximately 70% and decreasing radiation dose to critical organs by 50% [4] - The CT-Linac AI adaptive solution integrates AI with radiotherapy, enabling dynamic optimization of treatment plans within 10-15 minutes [4] Localization and Global Impact - Varian's localization strategy emphasizes "serving China" while also benefiting global markets, with its Beijing production base exporting to over 90 countries [5][6] - The company has developed a robust local supply chain, collaborating with over 50 Chinese suppliers and creating approximately 30,000 jobs [6] Future Directions - Varian aims to enhance its role as an ecosystem builder in China, focusing on three key areas: continuous technological innovation, empowering grassroots healthcare through automation, and deepening collaboration with Siemens Healthineers for comprehensive cancer management [6][7]